Is Femasys Inc (FEMY) overvalued? · rev $1.6M
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
This page asks whether Femasys Inc (FEMY) looks expensive on cached numbers — not a short thesis.
Latest reported FEMY revenue for 2024-12-31 was $1.6M. Net income was -$18.8M. Revenue was up 52.0% from 2023-12-31 to 2024-12-31. FEMY currently screens at market cap $925.2K.
FEMY currently screens at market cap $925.2K. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next FEMY 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the FEMY stock page for the full model, not this heading.
Not investment advice.